Lin Shih-Ying, Lin Hung-Ying, Sun Jui-Sheng, Chang Jenny Zwei-Chieng
Department of dentistry, MacKay Memorial Hospital, Taipei, Taiwan.
School of Dentistry, College of Medicine, National Taiwan University, Taipei, Taiwan.
Jpn Dent Sci Rev. 2025 Dec;61:167-187. doi: 10.1016/j.jdsr.2025.07.001. Epub 2025 Jul 14.
This study evaluates the effectiveness of adjunctive therapies combined with non-surgical periodontal treatment for Stage III/IV Grade C periodontitis, focusing on pocket depth (PD) reduction, clinical attachment level (CAL) gain, and adverse events. A systematic review and network meta-analysis were conducted, including randomized controlled trials up to September 2024. Inconsistencies and publication bias were detected, prompting sensitivity analyses and effectiveness rankings of adjunctive therapies. Data from 50 studies were included, with 45 entered into network meta-analysis, covering 24 interventions and 1431 patients. Compared to scaling and root planing (SRP) alone, adjunctive systemic lincosamides with nitroimidazole (Mac/Linc+Nitro-S) demonstrated the greatest PD reduction, followed by local statins (Statins-L) in the short term (≤3 months). Statins-L also provided the highest CAL gain. In the medium term (4-6 months), Statins-L remained the most effective, followed by bisphosphonates. For long-term (>6 months) follow-up, where fewer treatment approaches were available, Nitro-S achieved the most significant PD reduction and CAL gain, followed by Mac/Linc-S. Adverse effects were mild and self-limiting. Despite promising findings, inconsistencies in CAL outcomes and potential publication bias highlight the need for further research to confirm long-term safety and efficacy.
本研究评估辅助治疗联合非手术牙周治疗对III/IV期C级牙周炎的有效性,重点关注牙周袋深度(PD)降低、临床附着水平(CAL)增加和不良事件。进行了一项系统评价和网络荟萃分析,纳入截至2024年9月的随机对照试验。检测到不一致性和发表偏倚,从而促使对辅助治疗进行敏感性分析和有效性排名。纳入了50项研究的数据,其中45项纳入网络荟萃分析,涵盖24种干预措施和1431名患者。与单纯龈下刮治和根面平整(SRP)相比,辅助全身应用林可酰胺类与硝基咪唑类药物(Mac/Linc+Nitro-S)在短期内(≤3个月)牙周袋深度降低最为显著,其次是局部应用他汀类药物(Statins-L)。Statins-L在临床附着水平增加方面也最为显著。在中期(4 - 6个月),Statins-L仍然是最有效的,其次是双膦酸盐类。对于长期(>6个月)随访,由于可用的治疗方法较少,硝基咪唑类药物(Nitro-S)在牙周袋深度降低和临床附着水平增加方面最为显著,其次是Mac/Linc-S。不良反应轻微且为自限性。尽管有这些有前景的发现,但临床附着水平结果的不一致性和潜在的发表偏倚凸显了进一步研究以确认长期安全性和有效性的必要性。